Pilot Study to Evaluate Subcutaneous Abatacept vs Placebo in RA Patients With Hepatitis B on Entecavir Background- a Pilot, Double-blind, Placebo-controlled, Randomized, Controlled Trial.
Phase of Trial: Phase II
Latest Information Update: 29 Jun 2016
At a glance
- Drugs Abatacept (Primary)
- Indications Rheumatoid arthritis
- Focus Adverse reactions
- 18 Aug 2014 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 10 Mar 2014 New trial record